CAH

Cardinal Health
D

CAH

Arincen75/100B
271.74
USD
3.96
(1.48%)
Post Trading·270.81USD-0.93(-0.34%)
Last updated: · Delayed 15 min
Fair value327.68Plus-17%246Price 271.74410
Q1 FY2027 results
EPS3.26+10.9%Revenue67.51B+1.3%
OverviewFinancialsForecastEarningsDividendsCompany

Cardinal Health revenue 1986–2027

Cardinal Health's revenue in Q1 FY2027, the three months to 30 September 2026, was 67.51B USD, up 5.5% on the same quarter a year before. Cardinal Health's revenue over the last twelve months was 257.75B USD, up 10.0% on the twelve months before. In fiscal year 2026 it was 254.25B USD, up 14.2% on the year before.

Last updated 7 Nov 2026 · Next report 4 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 2026257.75B+10.00%10.05B1.82B
FY202630 Jun 2026254.25B+14.23%9.77B1.71B
FY202530 Jun 2025222.58B-1.87%8.17B1.56B
FY202430 Jun 2024226.83B+10.66%7.41B852.00M
FY202330 Jun 2023204.98B+13.04%6.89B330.00M
FY202230 Jun 2022181.33B+11.61%6.48B-938.00M
FY202130 Jun 2021162.47B+6.24%6.78B611.00M
FY202030 Jun 2020152.92B+5.08%6.87B-3.69B
FY201930 Jun 2019145.53B+6.38%6.83B1.36B
FY201830 Jun 2018136.81B+5.26%7.18B256.00M
FY201730 Jun 2017129.98B+6.94%6.54B1.29B
FY201630 Jun 2016121.55B+18.55%6.54B1.43B
FY201530 Jun 2015102.53B+12.57%5.71B1.22B
FY201430 Jun 201491.08B-9.90%5.16B1.17B
FY201330 Jun 2013101.09B-6.01%4.92B334.00M
FY201230 Jun 2012107.55B+4.78%4.54B1.07B
FY201130 Jun 2011102.64B+4.20%4.16B959.00M
FY201030 Jun 201098.50B+2.62%3.78B642.20M
FY200930 Jun 200995.99B+9.82%5.53B1.15B
FY200830 Jun 200887.41B+0.64%5.63B1.30B
FY200730 Jun 200786.85B+9.02%5.25B1.93B
FY200630 Jun 200679.66B+9.63%5.28B1.00B
FY200530 Jun 200572.67B+12.62%5.01B1.05B
FY200430 Jun 200464.52B+13.73%4.74B1.47B
FY200330 Jun 200356.73B+10.94%4.51B1.41B
FY200230 Jun 200251.14B+6.65%4.05B1.06B
FY200130 Jun 200147.95B+25.03%3.61B857.40M
FY200030 Jun 200038.35B+52.72%3.13B679.70M
FY199930 Jun 199925.11B+19.15%2.82B456.30M
FY199830 Jun 199821.08B+14.58%1.11B247.10M
FY199730 Jun 199718.39B+98.93%956.20M181.10M
FY199630 Jun 19969.25B+10.83%747.80M111.90M
FY199530 Jun 19958.34B+44.07%485.70M85.00M
FY199430 Jun 19945.79B+194.45%372.20M35.10M
FY199330 Jun 19931.97B+19.36%134.00M33.60M
FY199230 Jun 19921.65B+39.12%115.50M25.20M
FY199130 Jun 19911.18B+35.52%87.10M17.40M
FY199030 Jun 1990873.90M+24.77%63.30M12.80M
FY198931 Mar 1989700.40M+33.51%50.30M8.80M
FY198831 Mar 1988524.60M-19.58%37.20M6.60M
FY198731 Mar 1987652.30M+52.05%50.20M5.40M
FY198631 Mar 1986429.00M—32.60M6.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Cardinal Health revenue growth by segment

FY2026 against FY2025

Pharmaceutical Member234.83B
+14.8%
GMPD12.72B
+0.7%
Other Operating6.79B
+26.2%

Cardinal Health revenue by segment over time

Pharmaceutical Member GMPD Other Operating Medical Member Cardinal Health At Home Solutions Nuclear Precision Health Services
Fiscal yearPharmaceutical MemberGMPDOther OperatingMedical MemberCardinal Health At Home SolutionsNuclear Precision Health Services
FY2026234.83B +14.8%12.72B +0.7%6.79B +26.2%— — —
FY2025204.64B -2.6%12.64B +2.1%5.38B +19.3%— — —
FY2024210.02B +11.2%12.38B 4.51B — — —
FY2023188.81B +14.7%— — 12.37B -8.1%2.64B +8.9%1.20B +31.4%
FY2022164.58B +13.5%— — 13.46B -7.1%2.43B +10.1%911.00M +12.7%
FY2021144.99B +6.1%— — 14.49B +7.9%2.20B +9.3%808.00M +0.7%
FY2020136.69B +5.9%— — 13.43B -2.9%2.02B +11.9%802.00M -5.6%
FY2019129.07B +6.5%— — 13.83B -11.2%1.80B 850.00M
FY2018121.24B +4.1%— — 15.58B +15.2%— —
FY2017116.46B +6.7%— — 13.52B +8.8%— —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Cardinal Health's revenue

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.